Faeth Therapeutics, Inc. (FTH)
Market Closed
1 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
34. 51
+1.74
+5.3097%
After Hours
$
+2.49 +7.2153% 37. 00
844.77M Market Cap
- P/E Ratio
- Div Yield
276,713 Volume
- Eps
$ 32.77
Previous Close Want to track FTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Faeth Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 John H. Burbank III Passport Capital LLC | 1.29M | $32.16M | $41.6M | $9.44M | 29.36% |
 Li Peng China Universal Asset Management Co. Ltd. | 3,600 | $86,400 | $98,064 | $11,664 | 13.5% |
 George Song Superstring Capital Management LP | 14,175 | $354,375 | $458,419.5 | $104,044.5 | 29.36% |
 Olga Maltseva Catalio Capital Management LP | 14,718 | $126,280 | $475,980.12 | $349,700.12 | 276.92% |
 Matthew Richmond Richmond Investment Services, LLC | 79,731 | $1.99M | $2.17M | $178,597.44 | 8.96% |
| BGI B Group Inc. B Group Inc. | 610,169 | $15.25M | $19.73M | $4.48M | 29.36% |
